Block and bulk deals involve large transactions executed on stock exchanges. A block deal is defined as a single trade involving at least 5 lakh shares, or a total transaction value of Rs. 10 crore or more. In contrast, a bulk deal is characterised by transactions involving more than 0.5 percent of a company’s total equity shares.
Following is a list of two stocks that experienced notable price movements during the trading session of Thursday, following a bulk deal of up to 1.8 lakh equity shares executed on the NSE on Wednesday, 21st May. These fluctuations reflect investor sentiment and market reactions to the large-scale buying or selling activities observed during the trading session.
OneClick Logistics India Limited
With a market cap of Rs. 59.4 crores, the stock moved down by nearly 1 percent to Rs. 164.9 on NSE, during Thursday’s trading session. As per the latest bulk deal, GRSM Minerals & Metals LLP offloaded 39,600 equity shares, representing a 1.1 percent stake in the company, via an open market transaction on NSE. The transaction was valued at around Rs. 64.8 lakh, executed at an average price of Rs. 163.61 per share.
OneClick Logistics India Limited (OLIL) is an integrated logistics services and solutions provider engaged in the business of clearing and forwarding services. Its services can be broadly categorised as (i) non-vessel operating common carrier (NVOCC); (ii) ocean and air freight forwarding; (iii) bulk cargo handling; and (iv) custom clearance.
Accretion Pharmaceuticals Limited
With a market cap of Rs. 87.6 crores, the stock hit a 5 percent lower circuit at Rs. 78.8 on NSE, during Thursday’s trading session. Gretex Share Broking Limited sold nearly 1.4 lakh equity shares, representing a 1.26 percent stake in the company, via a bulk deal on NSE. The transaction was valued at around Rs. 1.16 crores, executed at an average price of Rs. 82.95 per share.
Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company engaged in the manufacturing and sales of tablets, capsules, and other healthcare products
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
